In the news
Beactica’s drug discovery platform delivers promise for brain tumour therapy
Article in SciTech Europa Quarterly 27
Beactica's CEO, Dr Per Källblad, explains how the company’s specialist small molecule drug discovery platform is developing a novel therapy for glioblastoma. Read full article here.